期刊文献+

自身免疫调节因子基因多态性与重症肌无力的相关性 被引量:1

Association between autoimmune regulator Gene Polymorphisms and Myasthenia gravis
下载PDF
导出
摘要 目的探索自身免疫调节因子AIRE基因rs3761389和rs1800520位点多态性与重症肌无力(MG)的易感性和严重程度的相关性。方法采用i MLDR技术对AIRE基因rs3761389和rs1800520位点进行基因分型,比较等位基因频率在480例MG患者(MG组)、487例健康对照者(对照组)以及MG各亚组的分布。在共显性、加性和过显性遗传模型下比较基因型频率。结果 rs3761389位点G等位基因MG组高于对照组,差异有统计学意义(P=0.035),基因型频率在加性模型下差异有统计学意义(P=0.046)。rs1800520位点MG组与对照组比较差异均无统计学意义。结论 AIRE基因rs3761389位点可能与MG的易感性相关,未发现其与MG严重程度相关;未发现rs1800520位点与MG的易感性和严重程度相关。 Objective To explore the association between autoimmune regulator ( AIRE) gene polymorphism and the susceptibility and severity of myasthenia gravis ( MG ) .Methods The rs3761389 and rs1800520 polymorphisms were determined by iMLDR technique .The frequencies of alleles were compared between 480 MG patients(MG group) and 487 healthy controls(control group), as well as among subgroups of MG patients .Genotype frequencies were compared under codominant , log-additive and overdominant models .Results The frequency of G allele of rs3761389 in MG group was significantly higher than that in the control group ( P=0.035 ) .There were significant differences in the frequencies of rs 3761389 genotype between MG group and the control group under log-additive model (P=0.046).Rs1800520 showed no significant differences in the frequencies of alleles and genotypes between MG group and control group .Conclusions The rs3761389 polymorphisms of AIRE gene may be associated with the susceptibility of MG ,but not with the severity of MG .The rs1800520 polymorphisms may not be associated with the susceptibility and severity of MG .
出处 《临床神经病学杂志》 CAS 北大核心 2015年第3期167-171,共5页 Journal of Clinical Neurology
基金 国家自然科学基金项目(81070963) 山东省自然科学基金(ZR2010HM019)
关键词 重症肌无力 自身免疫调节因子 基因多态性 易感性 严重程度 myasthenia gravis autoimmune regulator gene polymorphism susceptibility severity
  • 相关文献

参考文献14

  • 1Mathis D, Benoist C. A decade of AIRE [ J ]. Nat Rev Immunol, 2007, 7 : 645.
  • 2Wengraf DA, McDonagh A J, Lovewell TR, et al. Genetic analysis of autoimmune regulator haplotypes in alopecia areata[ J]. Tissue Anti- gens, 2008, 71: 206.
  • 3Terao C, Yamada R, Ohmura K, et al. The human AIRE gene at chromosome 21q22 is a genetic determinant for the predisposition to rheumatoid arthritis in Japanese population [ J ]. Hum Mol Genet, 2011, 20: 2680.
  • 4唐天萍,洪宇,谢琰臣,孙仁诚,张栩,王琦,杨雯茹,夏梦,高翔,徐昕,姚如永,周晓彬,李海峰.补体C3基因rs7951位点多态性与重症肌无力的相关性研究[J].中风与神经疾病杂志,2013,30(4):320-324. 被引量:4
  • 5Aarli JA. Myasthenia gravis in the elderly: is it different[ J]. Ann N Y Acad Sci, 2008, 1132: 238.
  • 6Mygland A, Tysnes OB, Matre R, et al. Anti-cardiac ryanodine re- ceptor antibodies in thymoma associated myasthenia gravis [ J ]. Auto- immunity, 1994, 17: 327.
  • 7Grob D, Brunner N, Namba T, et al. Lifetime course of myasthenia gravis[J]. Muscle Nerve, 2008, 37: 141.
  • 8Fattorossi A, Battaglia A, Buzzonetti A, et al. Circulating and thy- mic CD4 ^+ CD25^+T regulatory cells in myasthenia gravis : effect of immunosuppressive treatment [ J ]. Immunology, 2005, 116 : 134.
  • 9Aricha R, Feferman T, Berrih-Aknin Set al. Experimental myasthe- nia gravis in AIRE-deficient mice: a link between AIRE and regula- tory T cells[J]. Ann N Y Acad Sci, 2012, 1275 : 107.
  • 10Aschenbrenner K, D 'Cruz LM, Vollmann EH, et al. Selection of Foxp3 + regulatory T cells specific for self antigen expressed and presented by Aire + medullary thymic epithelial cells [ J ]. Nat Im- munol, 2007, 8: 351.

二级参考文献13

  • 1Kusner LL, Kaminski HJ. The role of complement in experimental au- toimmune myasthenia gravis[ J]. Ann N Y Acad Sci ,2012, 1274( 1 ) : 127 - 132.
  • 2Romi F, Kristoffersen EK, Aarli JA, et al. The role of complement in myasthenia gravis : serological evidence of complement consumption in vivo[ J ]. J Neuroimmuno1,2005,158 ( 1 ) : 191 - 194.
  • 3Liu A,Lin H,Liu Y,et al. Correlation of C3 level with severity of gener- alized myasthenia gravis [ J ]. Muscle Nerve,2009,40 (5) :801 - 808.
  • 4Miyagawa H, Yamai M, Sakaguchi D, et al. Association of polymor- phisms in complement component C3 gene with susceptibility to sys- temic lupus erythematosus [ J ]. Rheumatology ( Oxford ), 2008,47 (2) :158 -164.
  • 5Aarli JA. Myasthenia gravis in the elderly:Is it different [ J ]. Ann N Y Acad Sei ,2008,1132:238 - 243.
  • 6Osserman KE, Genkins G. Studies in myasthenia gravis : review of a twenty-year experience in over 1200 patients [ J ]. Mt Sinai J Med, 1971,38(6) :497 -537.
  • 7Mygland A, Tysnes OB, Matre R, et al. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis [ J ] . Autoimmu- nity, 1994,17 (4) :327 - 331.
  • 8Jaretzki A, Barohn ILl, Ernstoff RM, et al. Myasthenia gravis : recom- mendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of A- merica[ J]. Neurology ,2000,55 ( 1 ) : 16 - 23.
  • 9Grob D, Brunner N, Namba T, et al. Lifetime course of myasthenia gra- vis[ J]. Muscle Nerve ,2008,37(2) :141 - 149.
  • 10Chen X,Li S, Yang Y, et al. Genome-wide association study valida- tion identifies novel loci for atherosclerotic cardiovascular disease [J]. J Thromb Haemost,2012,10(8) :1508 -1514.

共引文献3

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部